6/23/2021 2:05:42 AM
AstraZeneca Says Orpathys Approved In China For Lung Cancer And MET Gene Alterations
6/22/2021 2:05:30 AM
AstraZeneca: Koselugo Approved In EU For Children With NF1 And Plexiform Neurofibromas
6/8/2021 9:32:40 AM
PathAI To Present Machine Learning-based Quality Control Tool For HER2 Testing In Breast Cancer
6/7/2021 2:08:43 AM
AstraZeneca Says ELEVATE-TN Trial Shows Favourable Tolerability At Four Years
6/4/2021 8:16:14 AM
Akoya And AstraZeneca To Collaborate On Spatial Biology Approach To Profiling Tumor-Immune Biology
6/2/2021 5:08:05 AM
Proteros Enters Oncology Collaboration And License Agreement With AstraZeneca
5/27/2021 2:14:35 AM
AstraZeneca Prices EUR 800 Mln Bond Offering
5/26/2021 2:08:33 AM
AstraZeneca Announces Pricing Of Six Tranche Global Bond Offering Totalling $7 Bln
5/25/2021 7:08:12 AM
Silence Therapeutics Receives Remaining $40 Mln From AstraZeneca As Part Of Upfront Investment For SiRNA Collaboration
5/25/2021 2:23:44 AM
UK CMA To Assess AstraZeneca-Alexion Deal; Invites Comments On Transaction